檢索結果 - Cynthia Obiozor

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    1416TiP CodeBreak 200: A phase III multicenter study of sotorasib (AMG 510), a KRAS(G12C) inhibitor, versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC) harboring KRAS p.G12C mutation

    1416TiP CodeBreak 200: A phase III multicenter study of sotorasib (AMG 510), a KRAS(G12C) inhibitor, versus docetaxel in patients with previously treated advanced non-small cell lu... 由 Martin Reck, Alexander I. Spira, Benjamin Besse, Jennifer Moriatis Wolf, Ferdinandos Skoulidis, Hossein Borghaei, Kōichi Goto, K. Park, Frank Griesinger, Enriqueta Felip, Michael Boyer, Carlos H. Barrios, Glenwood Goss, Hui Yang, Cynthia Obiozor, Suresh S. Ramalingam

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    MO01.32 CodeBreaK 200: A Phase 3 Multicenter Study of Sotorasib, a KRAS(G12C) Inhibitor, versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring KRAS p.G12C Mutation

    MO01.32 CodeBreaK 200: A Phase 3 Multicenter Study of Sotorasib, a KRAS(G12C) Inhibitor, versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer (N... 由 Martin Reck, Alexander I. Spira, Benjamin Besse, Jennifer Moriatis Wolf, Ferdinandos Skoulidis, Hossein Borghaei, Kōichi Goto, K. Park, Frank Griesinger, E. Felip Font, Michael Boyer, Carlos H. Barrios, Glenwood Goss, Hui Yang, Cynthia Obiozor, Suresh S. Ramalingam

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)

    989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP) 由 Mark M. Awad, Giacomo Pelizzari, James Stevenson, M. Majem Tarruella, C.G.M. Ferreira, W. Petty, Edurne Arriola, Javier de Castro, Igor Alexandre Protzner Morbeck, Jessica R. Bauman, Luca Toschi, A. Zer, Giulio Metro, S. Kalmadi, Andrés Martinez, C. Xia, A. Meloni, Cynthia Obiozor, N. Maimon, S. Novello

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    R‐<scp>CHOP </scp><i>versus</i> dose‐adjusted R‐<scp>EPOCH</scp> in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis

    R‐<scp>CHOP </scp><i>versus</i> dose‐adjusted R‐<scp>EPOCH</scp> in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis 由 Nirav N. Shah, Anikó Szabó, Scott F. Huntington, Narendranath Epperla, Nishitha Reddy, Siddhartha Ganguly, Julie M. Vose, Cynthia Obiozor, Fahad Faruqi, Alexandra E. Kovach, Luciano J. Costa, Ana C. Xavier, Ryan Okal, Abraham S. Kanate, Nilanjan Ghosh, Mohamed A. Kharfan‐Dabaja, Lauren E. Strelec, Mehdi Hamadani, Timothy S. Fenske, Oscar Calzada, Jonathon B. Cohen, Julio C. Chávez, Jakub Svoboda

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: